3SL3 - JenaLib

Asymmetric Unit (82, 82)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	LYS A:262 , ASP A:266 , HOH A:550 , HOH A:588 , HOH B:531	BINDING SITE FOR RESIDUE EDO A 1
02	AC2	SOFTWARE	EDO A:20 , LEU A:188 , LYS A:255 , GLN A:256 , DMS D:6 , GLU D:182	BINDING SITE FOR RESIDUE EDO A 2
03	AC3	SOFTWARE	EDO A:9 , ASN A:115 , ARG A:116 , GLU A:150 , ASP A:151 , TYR A:153 , ASN A:162 , HOH A:545	BINDING SITE FOR RESIDUE EDO A 3
04	AC4	SOFTWARE	PHE A:238 , ARG A:257 , HOH A:590 , HOH A:602	BINDING SITE FOR RESIDUE EDO A 4
05	AC5	SOFTWARE	EDO A:12 , ASP A:156 , ALA A:158 , PRO A:205 , ARG A:342 , ARG A:346 , HOH A:599	BINDING SITE FOR RESIDUE EDO A 5
06	AC6	SOFTWARE	EDO A:7 , PHE A:135 , GLN A:256 , HOH A:511 , DMS D:6	BINDING SITE FOR RESIDUE EDO A 6
07	AC7	SOFTWARE	EDO A:6 , THR A:134 , LYS A:136 , EDO D:9 , PRO D:179 , ASP D:391	BINDING SITE FOR RESIDUE EDO A 7
08	AC8	SOFTWARE	GLN A:250 , ASN A:251 , HOH A:548 , HOH A:577 , HOH D:556	BINDING SITE FOR RESIDUE EDO A 8
09	AC9	SOFTWARE	EDO A:3 , ASP A:151 , TYR A:153 , HIS A:154 , ALA A:155 , HOH A:545 , ASP C:156 , HOH C:483	BINDING SITE FOR RESIDUE EDO A 9
10	BC1	SOFTWARE	THR A:178 , ASP A:391	BINDING SITE FOR RESIDUE EDO A 10
11	BC2	SOFTWARE	PO4 A:16 , GLU A:230 , THR A:271 , ASP A:272 , MET A:273 , HOH A:567 , HOH A:574	BINDING SITE FOR RESIDUE EDO A 11
12	BC3	SOFTWARE	EDO A:5 , HIS A:154 , ASP A:156 , VAL A:157 , PRO A:205 , HOH C:474	BINDING SITE FOR RESIDUE EDO A 12
13	BC4	SOFTWARE	LEU A:132 , LYS A:136 , ILE A:137	BINDING SITE FOR RESIDUE PEG A 13
14	BC5	SOFTWARE	PO4 A:16 , ASP A:201 , HOH A:528 , HOH A:529 , HOH A:573 , HOH A:574	BINDING SITE FOR RESIDUE ZN A 14
15	BC6	SOFTWARE	PO4 A:16 , HIS A:164 , HIS A:200 , ASP A:201 , ASP A:318 , HOH A:573	BINDING SITE FOR RESIDUE ZN A 15
16	BC7	SOFTWARE	EDO A:11 , ZN A:14 , ZN A:15 , HIS A:160 , HIS A:164 , ASP A:201 , ASP A:318 , HOH A:509 , HOH A:530 , HOH A:573	BINDING SITE FOR RESIDUE PO4 A 16
17	BC8	SOFTWARE	LYS A:275	BINDING SITE FOR RESIDUE EDO A 17
18	BC9	SOFTWARE	HIS A:204 , GLY A:206 , VAL A:207 , GLU A:339 , PHE A:340 , GLN A:343	BINDING SITE FOR RESIDUE EDO A 18
19	CC1	SOFTWARE	THR A:148 , HIS A:152 , GLU A:243 , HOH A:555 , SER C:217 , ARG C:350	BINDING SITE FOR RESIDUE EDO A 19
20	CC2	SOFTWARE	EDO A:2 , THR A:186 , LEU A:188 , SER A:259 , MET A:263 , HOH A:580	BINDING SITE FOR RESIDUE EDO A 20
21	CC3	SOFTWARE	LYS A:239 , GLN A:242 , GLU A:243 , EDO C:18 , ASN C:216 , SER C:217 , GLU C:218 , GLN D:242	BINDING SITE FOR RESIDUE EDO A 21
22	CC4	SOFTWARE	DMS B:15 , GLN B:210 , HOH B:511 , HOH B:531	BINDING SITE FOR RESIDUE EDO B 1
23	CC5	SOFTWARE	ALA B:183 , VAL B:184	BINDING SITE FOR RESIDUE EDO B 2
24	CC6	SOFTWARE	THR B:289 , LYS B:291 , LEU B:298 , LEU B:299	BINDING SITE FOR RESIDUE EDO B 3
25	CC7	SOFTWARE	ASN B:115 , ALA B:155 , ASN B:161 , ASN B:162 , ARG B:335	BINDING SITE FOR RESIDUE EDO B 4
26	CC8	SOFTWARE	LEU B:175 , THR B:178 , TRP B:384 , ASP B:391	BINDING SITE FOR RESIDUE EDO B 5
27	CC9	SOFTWARE	ASP B:374 , HIS B:378 , HOH B:541	BINDING SITE FOR RESIDUE EDO B 6
28	DC1	SOFTWARE	DMS B:14 , HIS B:204 , GLY B:206 , VAL B:207 , GLU B:339 , PHE B:340 , GLN B:343 , HOH B:517	BINDING SITE FOR RESIDUE EDO B 7
29	DC2	SOFTWARE	PO4 B:10 , ASP B:201 , HOH B:524 , HOH B:525 , HOH B:526 , HOH B:569	BINDING SITE FOR RESIDUE ZN B 8
30	DC3	SOFTWARE	PO4 B:10 , HIS B:164 , HIS B:200 , ASP B:201 , ASP B:318 , HOH B:569	BINDING SITE FOR RESIDUE ZN B 9
31	DC4	SOFTWARE	ZN B:8 , ZN B:9 , HIS B:160 , HIS B:164 , ASP B:201 , ASP B:318 , HOH B:567 , HOH B:569 , HOH B:574	BINDING SITE FOR RESIDUE PO4 B 10
32	DC5	SOFTWARE	GLU B:218 , HIS D:152 , LYS D:239 , HOH D:594	BINDING SITE FOR RESIDUE EDO B 11
33	DC6	SOFTWARE	ILE B:354 , SER B:355 , MET B:357 , CYS B:358 , ASP B:359 , ASN B:362	BINDING SITE FOR RESIDUE EDO B 12
34	DC7	SOFTWARE	ASP B:334 , MET B:337 , GLU B:338 , PHE B:341	BINDING SITE FOR RESIDUE EDO B 13
35	DC8	SOFTWARE	EDO B:7 , SER B:208 , GLN B:343 , PRO B:356 , CYS B:358 , HOH B:565	BINDING SITE FOR RESIDUE DMS B 14
36	DC9	SOFTWARE	EDO B:1 , GLN B:210 , SER B:274 , HOH B:577 , HOH B:584	BINDING SITE FOR RESIDUE DMS B 15
37	EC1	SOFTWARE	THR B:186 , ASP B:187 , HOH B:582	BINDING SITE FOR RESIDUE EDO B 16
38	EC2	SOFTWARE	HIS B:152 , GLU B:243 , HOH B:519 , THR D:215 , SER D:217 , GLU D:218 , LEU D:219 , ARG D:350	BINDING SITE FOR RESIDUE PEG B 17
39	EC3	SOFTWARE	ARG A:350 , HIS C:152 , GLU C:243	BINDING SITE FOR RESIDUE EDO C 1
40	EC4	SOFTWARE	GLU A:244 , ASN C:214 , ARG C:350 , MET C:352 , HOH C:506 , LYS D:254	BINDING SITE FOR RESIDUE EDO C 7
41	EC5	SOFTWARE	GLU A:218 , TYR C:223 , HIS C:232 , ALA C:235 , HOH C:463	BINDING SITE FOR RESIDUE EDO C 2
42	EC6	SOFTWARE	ASP A:156 , EDO C:13 , GLU C:150 , ASP C:151 , TYR C:153 , ASN C:162	BINDING SITE FOR RESIDUE EDO C 3
43	EC7	SOFTWARE	HIS C:105 , VAL C:106 , PHE C:107 , ARG C:108 , GLU C:111 , GLN C:327 , LEU C:328 , GLN C:331	BINDING SITE FOR RESIDUE EPE C 4
44	EC8	SOFTWARE	ARG C:257 , ARG C:261	BINDING SITE FOR RESIDUE DMS C 5
45	EC9	SOFTWARE	LYS C:262 , ASP C:266 , ASN D:224	BINDING SITE FOR RESIDUE EDO C 6
46	FC1	SOFTWARE	LYS C:275 , HOH C:465	BINDING SITE FOR RESIDUE EDO C 12
47	FC2	SOFTWARE	HIS B:389 , PRO B:390 , THR C:134 , PHE C:135 , LYS C:136 , ASN C:251 , GLN C:256	BINDING SITE FOR RESIDUE EDO C 8
48	FC3	SOFTWARE	ASP C:203 , LEU C:219	BINDING SITE FOR RESIDUE EDO C 9
49	FC4	SOFTWARE	ASP C:156 , VAL C:157 , PRO C:205 , ARG C:342 , ARG C:346 , HOH C:468 , HOH C:502	BINDING SITE FOR RESIDUE EDO C 10
50	FC5	SOFTWARE	HIS C:160 , HIS C:204 , GLY C:206 , VAL C:207 , GLU C:339 , PHE C:340 , GLN C:343	BINDING SITE FOR RESIDUE EDO C 11
51	FC6	SOFTWARE	EDO C:3 , ASN C:115 , ALA C:155 , ASN C:161 , ASN C:162 , ILE C:163	BINDING SITE FOR RESIDUE EDO C 13
52	FC7	SOFTWARE	PO4 C:16 , ASP C:201 , HOH C:456 , HOH C:457 , HOH C:458 , HOH C:459	BINDING SITE FOR RESIDUE ZN C 14
53	FC8	SOFTWARE	PO4 C:16 , HIS C:164 , HIS C:200 , ASP C:201 , ASP C:318 , HOH C:458	BINDING SITE FOR RESIDUE ZN C 15
54	FC9	SOFTWARE	ZN C:14 , ZN C:15 , HOH C:58 , HIS C:160 , HIS C:164 , ASP C:201 , ASP C:318 , HOH C:458	BINDING SITE FOR RESIDUE PO4 C 16
55	GC1	SOFTWARE	EDO A:21 , GLU A:243 , HOH A:555 , GLU C:218	BINDING SITE FOR RESIDUE EDO C 18
56	GC2	SOFTWARE	ASP D:266 , GLN D:311	BINDING SITE FOR RESIDUE EDO D 4
57	GC3	SOFTWARE	EDO A:2 , EDO A:6 , SER D:177 , PRO D:179 , GLU D:182 , HOH D:553	BINDING SITE FOR RESIDUE DMS D 6
58	GC4	SOFTWARE	SER B:217 , HOH B:502 , EDO D:23 , THR D:148 , HIS D:152 , GLU D:243	BINDING SITE FOR RESIDUE EDO D 1
59	GC5	SOFTWARE	EDO A:7 , THR A:134 , PHE A:135 , ASN A:251 , GLN A:256 , PRO D:179 , ASP D:391	BINDING SITE FOR RESIDUE EDO D 9
60	GC6	SOFTWARE	EDO D:5 , LEU D:175 , THR D:178 , VAL D:388 , ASP D:391 , HOH D:541	BINDING SITE FOR RESIDUE EDO D 2
61	GC7	SOFTWARE	LEU D:181 , ALA D:183 , VAL D:184 , PHE D:185 , HOH D:553	BINDING SITE FOR RESIDUE EDO D 3
62	GC8	SOFTWARE	GLU D:150 , ASP D:151 , TYR D:153 , ASN D:162	BINDING SITE FOR RESIDUE DMS D 25
63	GC9	SOFTWARE	EDO D:2 , ASN D:100 , LYS D:101 , TRP D:102 , HOH D:550	BINDING SITE FOR RESIDUE EDO D 5
64	HC1	SOFTWARE	ASN D:100 , GLU D:128 , HIS D:173 , SER D:177	BINDING SITE FOR RESIDUE EDO D 27
65	HC2	SOFTWARE	HIS D:123	BINDING SITE FOR RESIDUE EDO D 7
66	HC3	SOFTWARE	ASP C:225 , HOH C:461 , GLN D:258 , LYS D:262 , ASP D:266	BINDING SITE FOR RESIDUE PEG D 8
67	HC4	SOFTWARE	ASN D:302 , TYR D:303 , SER D:304	BINDING SITE FOR RESIDUE EDO D 10
68	HC5	SOFTWARE	THR D:186 , LEU D:188 , GLU D:189 , SER D:259 , MET D:263 , HOH D:523	BINDING SITE FOR RESIDUE PEG D 11
69	HC6	SOFTWARE	ASP D:247 , PHE D:249 , ARG D:257	BINDING SITE FOR RESIDUE EDO D 12
70	HC7	SOFTWARE	ASP D:156 , VAL D:157 , ALA D:158 , GLU D:338 , GLU D:339 , HOH D:605	BINDING SITE FOR RESIDUE EDO D 13
71	HC8	SOFTWARE	PRO D:325 , LEU D:326 , GLN D:327 , HOH D:582	BINDING SITE FOR RESIDUE EDO D 14
72	HC9	SOFTWARE	GLU D:244 , ASN D:245 , SER D:294 , GLY D:296 , HOH D:520	BINDING SITE FOR RESIDUE EDO D 15
73	IC1	SOFTWARE	THR D:134 , LYS D:136 , ASN D:251 , GLN D:256	BINDING SITE FOR RESIDUE EDO D 16
74	IC2	SOFTWARE	PO4 D:19 , ASP D:201 , HOH D:535 , HOH D:536 , HOH D:537	BINDING SITE FOR RESIDUE ZN D 17
75	IC3	SOFTWARE	PO4 D:19 , HIS D:164 , HIS D:200 , ASP D:201 , ASP D:318	BINDING SITE FOR RESIDUE ZN D 18
76	IC4	SOFTWARE	ZN D:17 , ZN D:18 , HIS D:160 , HIS D:164 , ASP D:201 , ASP D:318 , HOH D:574	BINDING SITE FOR RESIDUE PO4 D 19
77	IC5	SOFTWARE	MET D:286 , THR D:289 , ASP D:305	BINDING SITE FOR RESIDUE EDO D 20
78	IC6	SOFTWARE	GLN D:127 , HOH D:507	BINDING SITE FOR RESIDUE EDO D 21
79	IC7	SOFTWARE	ASP D:98 , LYS D:101 , TRP D:102	BINDING SITE FOR RESIDUE EDO D 22
80	IC8	SOFTWARE	THR B:215 , ARG B:350 , EDO D:1 , THR D:148 , GLU D:243 , GLU D:244 , CYS D:246 , HOH D:554	BINDING SITE FOR RESIDUE EDO D 23
81	IC9	SOFTWARE	ASN D:321 , THR D:333 , ILE D:336 , GLN D:369 , HOH D:529	BINDING SITE FOR RESIDUE EDO D 24
82	JC1	SOFTWARE	ASP D:266 , GLN D:311	BINDING SITE FOR RESIDUE EDO D 26

SS Bonds (0, 0)

Cis Peptide Bonds (4, 4)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (4, 16)

PROSITE Motifs (1, 4)

Exons (8, 32)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:327
 aligned with PDE4D_HUMAN | Q08499 from UniProtKB/Swiss-Prot  Length:809

    Alignment length:327
                                   394       404       414       424       434       444       454       464       474       484       494       504       514       524       534       544       554       564       574       584       594       604       614       624       634       644       654       664       674       684       694       704       
          PDE4D_HUMAN   385 GVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQST 711
               SCOP domains d3sl3a_ A: Catalytic domain of cyclic nucleotide phosphodiesterase pde4d                                                                                                                                                                                                                                                                SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...hhhhhhhhhhhhhh.....hhhhhhhhh..hhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhh.......hhhhhhhh.hhhhhhh...hhhhhhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh............hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..............hhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--A----------------------------------------------------------------------------------D----T--------------------------------- SAPs(SNPs)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------PDEASE_I    ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ PROSITE
           Transcript 1 (1) Exon 1.34   Exon 1.35  PDB: A:95-127         Exon 1.36  PDB: A:128-182 UniProt: 430-484             Exon 1.37  PDB: A:183-216         ---------------------------------------------------Exon 1.39  PDB: A:268-308                Exon 1.40  PDB: A:309-369 UniProt: 611-671                   Exon 1.41j  PDB: A:370-409 [INCOMPLETE]  Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------------------------------------------------------------------Exon 1.38  PDB: A:216-267 UniProt: 518-569          ---------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 3sl3 A  83 GVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQST 409
                                    92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402

Chain B from PDB  Type:PROTEIN  Length:320
 aligned with PDE4D_HUMAN | Q08499 from UniProtKB/Swiss-Prot  Length:809

    Alignment length:320
                                   403       413       423       433       443       453       463       473       483       493       503       513       523       533       543       553       563       573       583       593       603       613       623       633       643       653       663       673       683       693       703       713
          PDE4D_HUMAN   394 LAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIP 713
               SCOP domains d3sl3b_ B: Catalytic domain of cyclic nucleotide phosphodiesterase pde4d                                                                                                                                                                                                                                                         SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..hhhhhh.....hhhhhhhhh..hhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhh.......hhhhhhhh.hhhhhhh...hhhhhhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh............hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.............hhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--A----------------------------------------------------------------------------------D----T----------------------------------- SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------------------------------------------------PDEASE_I    -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) 1.3Exon 1.35  PDB: B:95-127         Exon 1.36  PDB: B:128-182 UniProt: 430-484             Exon 1.37  PDB: B:183-216         ---------------------------------------------------Exon 1.39  PDB: B:268-308                Exon 1.40  PDB: B:309-369 UniProt: 611-671                   Exon 1.41j  PDB: B:370-411 [INCOMPLETE]    Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------------------------------Exon 1.38  PDB: B:216-267 UniProt: 518-569          ------------------------------------------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 3sl3 B  92 LAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIP 411
                                   101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411

Chain C from PDB  Type:PROTEIN  Length:324
 aligned with PDE4D_HUMAN | Q08499 from UniProtKB/Swiss-Prot  Length:809

    Alignment length:324
                                   398       408       418       428       438       448       458       468       478       488       498       508       518       528       538       548       558       568       578       588       598       608       618       628       638       648       658       668       678       688       698       708    
          PDE4D_HUMAN   389 EQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTI 712
               SCOP domains d3sl3c_ C: Catalytic domain of cyclic nucleotide phosphodiesterase pde4d                                                                                                                                                                                                                                                             SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author hhhhhhhhhhh.......hhhhhhhhh..hhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhh.......hhhhhhhh.hhhhhhh...hhhhhhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh............hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.............hhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--A----------------------------------------------------------------------------------D----T---------------------------------- SAPs(SNPs)
                    PROSITE -----------------------------------------------------------------------------------------------------------------PDEASE_I    ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) 1.34    Exon 1.35  PDB: C:95-127         Exon 1.36  PDB: C:128-182 UniProt: 430-484             Exon 1.37  PDB: C:183-216         ---------------------------------------------------Exon 1.39  PDB: C:268-308                Exon 1.40  PDB: C:309-369 UniProt: 611-671                   Exon 1.41j  PDB: C:370-410 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------------------------------------------------------------------Exon 1.38  PDB: C:216-267 UniProt: 518-569          ----------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 3sl3 C  87 EQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTI 410
                                    96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406

Chain D from PDB  Type:PROTEIN  Length:324
 aligned with PDE4D_HUMAN | Q08499 from UniProtKB/Swiss-Prot  Length:809

    Alignment length:324
                                   399       409       419       429       439       449       459       469       479       489       499       509       519       529       539       549       559       569       579       589       599       609       619       629       639       649       659       669       679       689       699       709    
          PDE4D_HUMAN   390 QEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIP 713
               SCOP domains d3sl3d_ D: Catalytic domain of cyclic nucleotide phosphodiesterase pde4d                                                                                                                                                                                                                                                             SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author hhhhhhhhhhhh.....hhhhhhhhh..hhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhh.......hhhhhhhh.hhhhhhh...hhhhhhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh............hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhh... Sec.struct. author
                 SAPs(SNPs) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--A----------------------------------------------------------------------------------D----T----------------------------------- SAPs(SNPs)
                    PROSITE ----------------------------------------------------------------------------------------------------------------PDEASE_I    -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) 1.34   Exon 1.35  PDB: D:95-127         Exon 1.36  PDB: D:128-182 UniProt: 430-484             Exon 1.37  PDB: D:183-216         ---------------------------------------------------Exon 1.39  PDB: D:268-308                Exon 1.40  PDB: D:309-369 UniProt: 611-671                   Exon 1.41j  PDB: D:370-411 [INCOMPLETE]    Transcript 1 (1)
           Transcript 1 (2) --------------------------------------------------------------------------------------------------------------------------------Exon 1.38  PDB: D:216-267 UniProt: 518-569          ------------------------------------------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 3sl3 D  88 QEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIP 411
                                    97       107       117       127       137       147       157       167       177       187       197       207       217       227       237       247       257       267       277       287       297       307       317       327       337       347       357       367       377       387       397       407

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 4)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (52, 52)

Asymmetric Unit(hide GO term definitions)

Chain A,B,C,D (PDE4D_HUMAN | Q08499)

molecular function
	GO:0004115	3',5'-cyclic-AMP phosphodiesterase activity	Catalysis of the reaction: adenosine 3',5'-cyclic phosphate + H2O = adenosine 5'-phosphate.
	GO:0004114	3',5'-cyclic-nucleotide phosphodiesterase activity	Catalysis of the reaction: nucleoside 3',5'-cyclic phosphate + H2O = nucleoside 5'-phosphate.
	GO:0051117	ATPase binding	Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP.
	GO:0031698	beta-2 adrenergic receptor binding	Interacting selectively and non-covalently with a beta-2 adrenergic receptor.
	GO:0030552	cAMP binding	Interacting selectively and non-covalently with cAMP, the nucleotide cyclic AMP (adenosine 3',5'-cyclophosphate).
	GO:0008144	drug binding	Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0044325	ion channel binding	Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0008081	phosphoric diester hydrolase activity	Catalysis of the hydrolysis of a phosphodiester to give a phosphomonoester and a free hydroxyl group.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0097110	scaffold protein binding	Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
	GO:0031625	ubiquitin protein ligase binding	Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
biological process
	GO:0050852	T cell receptor signaling pathway	A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
	GO:0071875	adrenergic receptor signaling pathway	A series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
	GO:0086024	adrenergic receptor signaling pathway involved in positive regulation of heart rate	An adrenergic receptor signaling pathway that contributes to an increase in frequency or rate of heart contraction. Binding of adrenalin or noradrenalin to a beta-adrenergic receptor on the surface of the signal-receiving cell results in the activation of an intracellular Gs protein. Gs activates adenylate cyclase to increase intracellular cyclic-AMP (cAMP) levels. cAMP binds directly to F-channels to allow an inward flow of sodium (known as funny current, or If current). The funny current is responsible for membrane depolarization and an increase in heart rate.
	GO:0007568	aging	A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
	GO:0006198	cAMP catabolic process	The chemical reactions and pathways resulting in the breakdown of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
	GO:0019933	cAMP-mediated signaling	Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
	GO:0071320	cellular response to cAMP	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
	GO:0071872	cellular response to epinephrine stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.
	GO:0071222	cellular response to lipopolysaccharide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0061028	establishment of endothelial barrier	The establishment of a barrier between endothelial cell layers, such as those in the brain, lung or intestine, to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition.
	GO:0050900	leukocyte migration	The movement of a leukocyte within or between different tissues and organs of the body.
	GO:0035264	multicellular organism growth	The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
	GO:0045822	negative regulation of heart contraction	Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction.
	GO:0033137	negative regulation of peptidyl-serine phosphorylation	Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.
	GO:1901898	negative regulation of relaxation of cardiac muscle	Any process that stops, prevents or reduces the frequency, rate or extent of relaxation of cardiac muscle.
	GO:0030593	neutrophil chemotaxis	The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
	GO:0032729	positive regulation of interferon-gamma production	Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
	GO:0032743	positive regulation of interleukin-2 production	Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.
	GO:0032754	positive regulation of interleukin-5 production	Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.
	GO:0030814	regulation of cAMP metabolic process	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
	GO:0086004	regulation of cardiac muscle cell contraction	Any process that modulates the frequency, rate or extent of cardiac muscle cell contraction.
	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	Any process that modulates the frequency, rate or extent of cell communication by electrical coupling involved in cardiac conduction.
	GO:0002027	regulation of heart rate	Any process that modulates the frequency or rate of heart contraction.
	GO:0010469	regulation of receptor activity	Any process that modulates the frequency, rate or extent of receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity.
	GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	Any process that modulates the rate, frequency or extent of release of sequestered calcium ion into cytosol by the sarcoplasmic reticulum, the process in which the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol occurs via calcium release channels.
	GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity	Any process that modulates the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0006939	smooth muscle contraction	A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length.
cellular component
	GO:0016324	apical plasma membrane	The region of the plasma membrane located at the apical end of the cell.
	GO:0034704	calcium channel complex	An ion channel complex through which calcium ions pass.
	GO:0005813	centrosome	A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005856	cytoskeleton	Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005815	microtubule organizing center	An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0005891	voltage-gated calcium channel complex	A protein complex that forms a transmembrane channel through which calcium ions may pass in response to changes in membrane potential.

Visualization

Interactive Views

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		DMS	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		EDO	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		EPE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		PEG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		PO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ZN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]
		CC1	[ RasMol ]	+environment [ RasMol ]
		CC2	[ RasMol ]	+environment [ RasMol ]
		CC3	[ RasMol ]	+environment [ RasMol ]
		CC4	[ RasMol ]	+environment [ RasMol ]
		CC5	[ RasMol ]	+environment [ RasMol ]
		CC6	[ RasMol ]	+environment [ RasMol ]
		CC7	[ RasMol ]	+environment [ RasMol ]
		CC8	[ RasMol ]	+environment [ RasMol ]
		CC9	[ RasMol ]	+environment [ RasMol ]
		DC1	[ RasMol ]	+environment [ RasMol ]
		DC2	[ RasMol ]	+environment [ RasMol ]
		DC3	[ RasMol ]	+environment [ RasMol ]
		DC4	[ RasMol ]	+environment [ RasMol ]
		DC5	[ RasMol ]	+environment [ RasMol ]
		DC6	[ RasMol ]	+environment [ RasMol ]
		DC7	[ RasMol ]	+environment [ RasMol ]
		DC8	[ RasMol ]	+environment [ RasMol ]
		DC9	[ RasMol ]	+environment [ RasMol ]
		EC1	[ RasMol ]	+environment [ RasMol ]
		EC2	[ RasMol ]	+environment [ RasMol ]
		EC3	[ RasMol ]	+environment [ RasMol ]
		EC4	[ RasMol ]	+environment [ RasMol ]
		EC5	[ RasMol ]	+environment [ RasMol ]
		EC6	[ RasMol ]	+environment [ RasMol ]
		EC7	[ RasMol ]	+environment [ RasMol ]
		EC8	[ RasMol ]	+environment [ RasMol ]
		EC9	[ RasMol ]	+environment [ RasMol ]
		FC1	[ RasMol ]	+environment [ RasMol ]
		FC2	[ RasMol ]	+environment [ RasMol ]
		FC3	[ RasMol ]	+environment [ RasMol ]
		FC4	[ RasMol ]	+environment [ RasMol ]
		FC5	[ RasMol ]	+environment [ RasMol ]
		FC6	[ RasMol ]	+environment [ RasMol ]
		FC7	[ RasMol ]	+environment [ RasMol ]
		FC8	[ RasMol ]	+environment [ RasMol ]
		FC9	[ RasMol ]	+environment [ RasMol ]
		GC1	[ RasMol ]	+environment [ RasMol ]
		GC2	[ RasMol ]	+environment [ RasMol ]
		GC3	[ RasMol ]	+environment [ RasMol ]
		GC4	[ RasMol ]	+environment [ RasMol ]
		GC5	[ RasMol ]	+environment [ RasMol ]
		GC6	[ RasMol ]	+environment [ RasMol ]
		GC7	[ RasMol ]	+environment [ RasMol ]
		GC8	[ RasMol ]	+environment [ RasMol ]
		GC9	[ RasMol ]	+environment [ RasMol ]
		HC1	[ RasMol ]	+environment [ RasMol ]
		HC2	[ RasMol ]	+environment [ RasMol ]
		HC3	[ RasMol ]	+environment [ RasMol ]
		HC4	[ RasMol ]	+environment [ RasMol ]
		HC5	[ RasMol ]	+environment [ RasMol ]
		HC6	[ RasMol ]	+environment [ RasMol ]
		HC7	[ RasMol ]	+environment [ RasMol ]
		HC8	[ RasMol ]	+environment [ RasMol ]
		HC9	[ RasMol ]	+environment [ RasMol ]
		IC1	[ RasMol ]	+environment [ RasMol ]
		IC2	[ RasMol ]	+environment [ RasMol ]
		IC3	[ RasMol ]	+environment [ RasMol ]
		IC4	[ RasMol ]	+environment [ RasMol ]
		IC5	[ RasMol ]	+environment [ RasMol ]
		IC6	[ RasMol ]	+environment [ RasMol ]
		IC7	[ RasMol ]	+environment [ RasMol ]
		IC8	[ RasMol ]	+environment [ RasMol ]
		IC9	[ RasMol ]	+environment [ RasMol ]
		JC1	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		His A:389 - Pro A:390	[ RasMol ]
		His B:389 - Pro B:390	[ RasMol ]
		His C:389 - Pro C:390	[ RasMol ]
		His D:389 - Pro D:390	[ RasMol ]

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]
		Biological Unit 3	[ Jena3D ]
		Biological Unit 4	[ Jena3D ]

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (6, 82)

Sites (82, 82)

SS Bonds (0, 0)

Cis Peptide Bonds (4, 4)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (4, 16)

PROSITE Motifs (1, 4)

Exons (8, 32)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 4)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (52, 52)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File